ARTICLE | Company News
FDA approves expanded Xiaflex label
October 22, 2014 3:53 AM UTC
FDA approved an sBLA from Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) for Xiaflex collagenase clostridium to treat up to two Dupuytren's contracture joints in the same hand during a single treatment visit. The injectable form of collagenase previously was approved for one collagen cord.
Auxilium said 35-40% of Dupuytren's surgeries are performed on multiple joints. The stock was up $0.53 to $31.12 on Tuesday. ...